Optimization of Smoking Cessation Strategies Concurrent With Treatment of Tobacco Related Malignancies
Public ClinicalTrials.gov record NCT02048917. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to find an optimal smoking cessation strategy in patients undergoing therapy for lung and head and neck cancers at selected cancer centers in Kentucky by delivering high quality smoking cessation to all enrolled patients. This study will also examine the feasibility of routinely implementing an array of smoking cessation strategies for this patient population.
Study identification
- NCT ID
- NCT02048917
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 93 participants
Conditions and interventions
Conditions
Interventions
- High Intensity Counseling + Long Acting NRT + PRN NRT Drug
- High Intensity Counseling + bupropion + PRN NRT Drug
- High Intensity Counseling + varenicline + PRN NRT Drug
- High Intensity Counseling + Long Acting NRT Drug
- High Intensity Counseling + bupropion Drug
- High Intensity Counseling + varenicline Drug
- Low Intensity Counseling + Long Acting NRT + PRN NRT Drug
- Low Intensity Counseling + bupropion + PRN NRT Drug
- Low Intensity Counseling + varenicline + PRN NRT Drug
- Low Intensity Counseling + Long Acting NRT Drug
- Low Intensity Counseling + bupropion Drug
- Low Intensity Counseling + varenicline Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2014
- Primary completion
- May 14, 2019
- Completion
- May 14, 2019
- Last update posted
- Jan 28, 2020
2014 – 2019
United States locations
- U.S. sites
- 10
- U.S. states
- 2
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| King's Daughters Medical Center | Ashland | Kentucky | 41101 | — |
| Hardin Memorial Health Cancer Care Center | Elizabethtown | Kentucky | 42701 | — |
| ARH Cancer Center | Hazard | Kentucky | 41701 | — |
| Kentucky Cancer Clinic | Hazard | Kentucky | 41701 | — |
| Lexington Veterans Affair Medical Center | Lexington | Kentucky | 40502 | — |
| University Of Kentucky, Markey Cancer Center | Lexington | Kentucky | 40536 | — |
| University of Louisville, James Graham Brown Cancer Center | Louisville | Kentucky | 40202 | — |
| St. Claire Regional Medical Center | Morehead | Kentucky | 40351 | — |
| Owensboro Health | Owensboro | Kentucky | 42303 | — |
| St. Mary's Medical Center | Huntington | West Virginia | 25702 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02048917, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 28, 2020 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02048917 live on ClinicalTrials.gov.